![]() |
|
|
Vol. 29, Issue 10, 1290-1295, October 2001
Drug Metabolism and Drug Disposition Group, College of Pharmacy and
Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
(S.C.V., E.M.H., G.M.); and Drug Disposition and Metabolism Department,
AstraZeneca, Wilmington, Delaware (D.J.M.).
A series of eight 1-substituted imidazoles was investigated as
model substrates for glucuronidation at an aromatic tertiary amine of
polyaza heterocyclic ring systems. The human
UDP-glucuronosyltransferases (UGTs) involved and substrate
specificities were
investigated. Nine expressed enzymes (UGT1A1, UGT1A3, UGT1A4,
UGT1A6, UGT1A7, UGT1A9, UGT1A10, UGT2B7, and UGT2B15) were examined,
but only UGT1A4 catalyzed the formation of a quaternary ammonium-linked
glucuronide metabolite for six of the substrates. UGT1A3 also catalyzed
the glucuronidation of the previously investigated 1-phenylimidazole
but none of the newly investigated compounds. No glucuronidation was
observed with 1-(4-nitrophenyl)imidazole, the compound with the
4-phenyl substituent with the largest electron withdrawing effect. The
incubation conditions for the determination of the kinetic constants
for UGT1A4 catalysis of six substrates were optimized and included
incubation at pH 7.4 with alamethicin at 10 µg/mg of protein. Latency
disrupting agents, including alamethicin and sonication, enhanced
glucuronidation 1.25-fold at most. There were 17.5- and 2.2-fold
variations in the apparent Km (range, 0.18-3.15 mM) and Vmax values (range,
0.16-0.35 nmol/min/mg of protein). Linear correlation analyses between
UGT1A4 kinetics and substrate physicochemical parameters showed
significant correlation between Vmax and
both the partition coefficient (log P, n-octanol/water) and pKa and between
Km and pKa,
thereby indicating that the lipophilicity and the ease of availability
of the tertiary amine lone pair of electrons of the substrate are
important with respect to enzyme catalysis.
This article has been cited by other articles:
![]() |
G. E. Kuehl and S. E. Murphy N-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., November 1, 2003; 31(11): 1361 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tang, J. H. Hochman, B. Ma, R. Subramanian, and K. P. Vyas Acyl Glucuronidation and Glucosidation of a New and Selective Endothelin ETA Receptor Antagonist in Human Liver Microsomes Drug Metab. Dispos., January 1, 2003; 31(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Vashishtha, E. M. Hawes, D. J. McCann, O. Ghosheh, and L. Hogg Quaternary Ammonium-Linked Glucuronidation of 1-Substituted Imidazoles by Liver Microsomes: Interspecies Differences and Structure-Metabolism Relationships Drug Metab. Dispos., October 1, 2002; 30(10): 1070 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ghosheh and E. M. Hawes N-Glucuronidation of Nicotine and Cotinine in Human: Formation of Cotinine Glucuronide in Liver Microsomes and Lack of Catalysis by 10 Examined UDP-Glucuronosyltransferases Drug Metab. Dispos., September 1, 2002; 30(9): 991 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ghosheh, S. C. Vashishtha, and E. M. Hawes Formation of the Quaternary Ammonium-Linked Glucuronide of Nicotine in Human Liver Microsomes: Identification and Stereoselectivity in the Kinetics Drug Metab. Dispos., December 1, 2001; 29(12): 1525 - 1528. [Abstract] [Full Text] [PDF] |
||||